# Runs - Clinical Trials 2021 

#### BARTRM3Filt 
[**`Results`**](./results.md#bartrm3filt) | [**`Participants`**](./participants.md#ims_unipd) | [**`Proceedings`**](./proceedings.md#filter-transform-expand-and-fuse-the-ims-unipd-at-trec-2021-clinical-trials) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.BARTRM3Filt.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.BARTRM3Filt) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/BARTRM3Filt.pdf) 

- :material-rename: **Run ID:** BARTRM3Filt 
- :fontawesome-solid-user-group: **Participant:** ims_unipd 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `2048c029831c3a6bbf6e1f83abb2217b` 
- :material-text: **Run description:** BM25 + BART embeddings + RM3 pseudo RF 

---
#### baseline 
[**`Results`**](./results.md#baseline) | [**`Participants`**](./participants.md#dossier) | [**`Proceedings`**](./proceedings.md#dossier-at-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.baseline.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.baseline) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/baseline.pdf) 

- :material-rename: **Run ID:** baseline 
- :fontawesome-solid-user-group: **Participant:** DOSSIER 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `bc0fb691792603337c3dc2ee6131e440` 
- :material-text: **Run description:** bm25 baseline 

---
#### bm25_text 
[**`Results`**](./results.md#bm25_text) | [**`Participants`**](./participants.md#heg_geneva) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.bm25_text.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.bm25_text) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/bm25_text.pdf) 

- :material-rename: **Run ID:** bm25_text 
- :fontawesome-solid-user-group: **Participant:** HEG_Geneva 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `f225bc74f0f117cd2be9dce6fd650723` 
- :material-text: **Run description:** BM25 model of the Elasticsearch on multiple CT fields with eligibility filtering. 

---
#### bm25_txt_map 
[**`Results`**](./results.md#bm25_txt_map) | [**`Participants`**](./participants.md#heg_geneva) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.bm25_txt_map.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.bm25_txt_map) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/bm25_txt_map.pdf) 

- :material-rename: **Run ID:** bm25_txt_map 
- :fontawesome-solid-user-group: **Participant:** HEG_Geneva 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `f3b34b044059b73e7f3d53dd8abd8d9b` 
- :material-text: **Run description:** RRF combination of two BM25 models, one based on the original query texts, one based on query expansion by the Metamap framework 

---
#### CincyMedIR_1 
[**`Results`**](./results.md#cincymedir_1) | [**`Participants`**](./participants.md#cincymedir) | [**`Proceedings`**](./proceedings.md#cincymedir-at-trec-2021-clinical-trial-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.CincyMedIR_1.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.CincyMedIR_1) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/CincyMedIR_1.pdf) 

- :material-rename: **Run ID:** CincyMedIR_1 
- :fontawesome-solid-user-group: **Participant:** CincyMedIR 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/16/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `af389386534b7ccfdc888ef86889ee44` 
- :material-text: **Run description:** Elasticsearch Match topic text against brief title, official title, brief summary, detailed description Filter by age, gender, recruiting status, exclusion criteria 

---
#### CincyMedIR_2 
[**`Results`**](./results.md#cincymedir_2) | [**`Participants`**](./participants.md#cincymedir) | [**`Proceedings`**](./proceedings.md#cincymedir-at-trec-2021-clinical-trial-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.CincyMedIR_2.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.CincyMedIR_2) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/CincyMedIR_2.pdf) 

- :material-rename: **Run ID:** CincyMedIR_2 
- :fontawesome-solid-user-group: **Participant:** CincyMedIR 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/16/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `53f0c0c8ce7a2a81db8bf723474a8bc5` 
- :material-text: **Run description:** Elasticsearch Match topic text against brief title, official title, brief summary, detailed description Filter by age, gender, recruiting status Rerank by exclusion criteria 

---
#### CincyMedIR_3 
[**`Results`**](./results.md#cincymedir_3) | [**`Participants`**](./participants.md#cincymedir) | [**`Proceedings`**](./proceedings.md#cincymedir-at-trec-2021-clinical-trial-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.CincyMedIR_3.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.CincyMedIR_3) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/CincyMedIR_3.pdf) 

- :material-rename: **Run ID:** CincyMedIR_3 
- :fontawesome-solid-user-group: **Participant:** CincyMedIR 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/16/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `bcf25d8c2b93ce036edd71c6a2bdbdd9` 
- :material-text: **Run description:** Elasticsearch Match topic text against brief title, official title, brief summary, detailed description Filter by age, gender, exclusion criteria Rerank by recruiting status 

---
#### CincyMedIR_4 
[**`Results`**](./results.md#cincymedir_4) | [**`Participants`**](./participants.md#cincymedir) | [**`Proceedings`**](./proceedings.md#cincymedir-at-trec-2021-clinical-trial-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.CincyMedIR_4.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.CincyMedIR_4) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/CincyMedIR_4.pdf) 

- :material-rename: **Run ID:** CincyMedIR_4 
- :fontawesome-solid-user-group: **Participant:** CincyMedIR 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/16/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `8d53e76d458b8bb8ee91ceadea7bcd4f` 
- :material-text: **Run description:** Elasticsearch Match topic text against brief title, official title, brief summary, detailed description Filter by age, gender Rerank by exclusion criteria first, and then recruiting status 

---
#### CincyMedIR_5 
[**`Results`**](./results.md#cincymedir_5) | [**`Participants`**](./participants.md#cincymedir) | [**`Proceedings`**](./proceedings.md#cincymedir-at-trec-2021-clinical-trial-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.CincyMedIR_5.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.CincyMedIR_5) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/CincyMedIR_5.pdf) 

- :material-rename: **Run ID:** CincyMedIR_5 
- :fontawesome-solid-user-group: **Participant:** CincyMedIR 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/16/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `76c95ee3796f3c8cefa4bceaba3cc490` 
- :material-text: **Run description:** Elasticsearch Match topic text against brief title, official title, brief summary, detailed description Filter by age, gender Rerank by recruiting status first, and then exclusion criteria 

---
#### CSIROmed_abs 
[**`Results`**](./results.md#csiromed_abs) | [**`Participants`**](./participants.md#csiromed) | [**`Proceedings`**](./proceedings.md#csiromed-team-report-of-trec-2021-clinical-trials-track-experiments-with-bert-reranking-methods) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.CSIROmed_abs.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.CSIROmed_abs) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/CSIROmed_abs.pdf) 

- :material-rename: **Run ID:** CSIROmed_abs 
- :fontawesome-solid-user-group: **Participant:** CSIROmed 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `e9b9bd889b9c710ab883a822a83c36f7` 
- :material-text: **Run description:** Lucene's DFR + BERT-based reranking with titles and summaries. 

---
#### CSIROmed_brd 
[**`Results`**](./results.md#csiromed_brd) | [**`Participants`**](./participants.md#csiromed) | [**`Proceedings`**](./proceedings.md#csiromed-team-report-of-trec-2021-clinical-trials-track-experiments-with-bert-reranking-methods) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.CSIROmed_brd.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.CSIROmed_brd) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/CSIROmed_brd.pdf) 

- :material-rename: **Run ID:** CSIROmed_brd 
- :fontawesome-solid-user-group: **Participant:** CSIROmed 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `03f278ab308bf1ab74319d20445578c9` 
- :material-text: **Run description:** Borda rank over other runs 

---
#### CSIROmed_DCT 
[**`Results`**](./results.md#csiromed_dct) | [**`Participants`**](./participants.md#csiromed) | [**`Proceedings`**](./proceedings.md#csiromed-team-report-of-trec-2021-clinical-trials-track-experiments-with-bert-reranking-methods) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.CSIROmed_DCT.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.CSIROmed_DCT) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/CSIROmed_DCT.pdf) 

- :material-rename: **Run ID:** CSIROmed_DCT 
- :fontawesome-solid-user-group: **Participant:** CSIROmed 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `7ceee1d03affb0dbd2a0ea4e922f211e` 
- :material-text: **Run description:** Lucene's DFR + DeepCT 

---
#### CSIROmed_inc 
[**`Results`**](./results.md#csiromed_inc) | [**`Participants`**](./participants.md#csiromed) | [**`Proceedings`**](./proceedings.md#csiromed-team-report-of-trec-2021-clinical-trials-track-experiments-with-bert-reranking-methods) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.CSIROmed_inc.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.CSIROmed_inc) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/CSIROmed_inc.pdf) 

- :material-rename: **Run ID:** CSIROmed_inc 
- :fontawesome-solid-user-group: **Participant:** CSIROmed 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `d3107b739e251f4c96663900efb09ca5` 
- :material-text: **Run description:** Lucene's DFR + BERT-based reranking with titles and inclusion criteria 

---
#### CSIROmedNIR 
[**`Results`**](./results.md#csiromednir) | [**`Participants`**](./participants.md#csiromed) | [**`Proceedings`**](./proceedings.md#csiromed-team-report-of-trec-2021-clinical-trials-track-experiments-with-bert-reranking-methods) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.CSIROmedNIR.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.CSIROmedNIR) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/CSIROmedNIR.pdf) 

- :material-rename: **Run ID:** CSIROmedNIR 
- :fontawesome-solid-user-group: **Participant:** CSIROmed 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `eac646e4e53ea1046ae0c58c502587b9` 
- :material-text: **Run description:** NIR (w. ES BM25) 

---
#### CuiInc 
[**`Results`**](./results.md#cuiinc) | [**`Participants`**](./participants.md#gu_biomed) | [**`Proceedings`**](./proceedings.md#clinical-trial-search-using-lucene-and-umls) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.CuiInc.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.CuiInc) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/CuiInc.pdf) 

- :material-rename: **Run ID:** CuiInc 
- :fontawesome-solid-user-group: **Participant:** GU_BioMed 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `ac39e10c5605f6227e0d9aea57577382` 
- :material-text: **Run description:** This run uses our own model based on the Apache Lucene search engine. In this run, all the patient profiles and the condition, inclusion criteria and exclusion criteria for each clinical study were converted to UMLS Concept Unique Identifiers (CUIs). While each patient profile was considered as a query, all the clinical study condition and inclusion criteria CUIs were organized into a database. For each patient, the search results were sorted using the Lucene scores searched against the database.  

---
#### CuiIncExc 
[**`Results`**](./results.md#cuiincexc) | [**`Participants`**](./participants.md#gu_biomed) | [**`Proceedings`**](./proceedings.md#clinical-trial-search-using-lucene-and-umls) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.CuiIncExc.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.CuiIncExc) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/CuiIncExc.pdf) 

- :material-rename: **Run ID:** CuiIncExc 
- :fontawesome-solid-user-group: **Participant:** GU_BioMed 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `38da8ae1f18a9485bf9b882bf4f56b43` 
- :material-text: **Run description:** This run uses our own model based on the Apache Lucene search engine. In this run, all the patient profiles and the condition, inclusion criteria and exclusion criteria for each clinical study were converted to UMLS Concept Unique Identifiers (CUIs). While all the clinical study condition and inclusion criteria CUIs were put in one database, the exclusion criteria CUIs were organized into another database. Using each patient profile with CUIs as a query, the search results were sorted using the difference of the two Lucene scores searched against the two databases, respectively. 

---
#### damoebr 
[**`Results`**](./results.md#damoebr) | [**`Participants`**](./participants.md#alibaba) | [**`Proceedings`**](./proceedings.md#alibaba-damo-academy-at-trec-clinical-trials-2021-exploringembedding-based-first-stage-retrieval-with-trialmatcher) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.damoebr.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.damoebr) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/damoebr.pdf) 

- :material-rename: **Run ID:** damoebr 
- :fontawesome-solid-user-group: **Participant:** ALIBABA 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `a84545ca4882b4e3a8046f73f0866aec` 
- :material-text: **Run description:** We use our own embedding-based first-stage retrieval system. 

---
#### damoebrsigir 
[**`Results`**](./results.md#damoebrsigir) | [**`Participants`**](./participants.md#alibaba) | [**`Proceedings`**](./proceedings.md#alibaba-damo-academy-at-trec-clinical-trials-2021-exploringembedding-based-first-stage-retrieval-with-trialmatcher) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.damoebrsigir.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.damoebrsigir) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/damoebrsigir.pdf) 

- :material-rename: **Run ID:** damoebrsigir 
- :fontawesome-solid-user-group: **Participant:** ALIBABA 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `02c4e87a634ee77190739b6301be3b45` 
- :material-text: **Run description:** We use our own embedding-based first-stage retrieval system and a reranker pre-trained by the SIGIR dataset.  

---
#### damoebrtog 
[**`Results`**](./results.md#damoebrtog) | [**`Participants`**](./participants.md#alibaba) | [**`Proceedings`**](./proceedings.md#alibaba-damo-academy-at-trec-clinical-trials-2021-exploringembedding-based-first-stage-retrieval-with-trialmatcher) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.damoebrtog.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.damoebrtog) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/damoebrtog.pdf) 

- :material-rename: **Run ID:** damoebrtog 
- :fontawesome-solid-user-group: **Participant:** ALIBABA 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `fc33eed95bc0ec8f11197c0d2b4521fe` 
- :material-text: **Run description:** We use our own embedding-based first-stage retrieval system. 

---
#### damohitl 
[**`Results`**](./results.md#damohitl) | [**`Participants`**](./participants.md#alibaba) | [**`Proceedings`**](./proceedings.md#alibaba-damo-academy-at-trec-clinical-trials-2021-exploringembedding-based-first-stage-retrieval-with-trialmatcher) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.damohitl.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.damohitl) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/damohitl.pdf) 

- :material-rename: **Run ID:** damohitl 
- :fontawesome-solid-user-group: **Participant:** ALIBABA 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** manual 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `20e094984287bdd21fa6de68fcae77f8` 
- :material-text: **Run description:** We use our own embedding-based first-stage retrieval system and an active learning-based reranker. 

---
#### damohitls 
[**`Results`**](./results.md#damohitls) | [**`Participants`**](./participants.md#alibaba) | [**`Proceedings`**](./proceedings.md#alibaba-damo-academy-at-trec-clinical-trials-2021-exploringembedding-based-first-stage-retrieval-with-trialmatcher) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.damohitls.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.damohitls) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/damohitls.pdf) 

- :material-rename: **Run ID:** damohitls 
- :fontawesome-solid-user-group: **Participant:** ALIBABA 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** manual 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `02bac216e6d22356c730d3413eca824c` 
- :material-text: **Run description:** We use our own embedding-based first-stage retrieval system and an active learning-based reranker.  

---
#### desc_rm3 
[**`Results`**](./results.md#desc_rm3) | [**`Participants`**](./participants.md#h2oloo) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.desc_rm3.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.desc_rm3) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/desc_rm3.pdf) 

- :material-rename: **Run ID:** desc_rm3 
- :fontawesome-solid-user-group: **Participant:** h2oloo 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `402c9312c3b40e17f3366e29cd298956` 
- :material-text: **Run description:** Pyserini's RM3 on the topic description. Default parameters. 

---
#### elastic 
[**`Results`**](./results.md#elastic) | [**`Participants`**](./participants.md#ntu_nlp) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.elastic.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.elastic) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/elastic.pdf) 

- :material-rename: **Run ID:** elastic 
- :fontawesome-solid-user-group: **Participant:** NTU_NLP 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `cee9561b22abdbd95030a8687e3cbc80` 
- :material-text: **Run description:** elasticsearch-based model and search by Amazon Comprehend Medical parsed weight 

---
#### embed_dense 
[**`Results`**](./results.md#embed_dense) | [**`Participants`**](./participants.md#heg_geneva) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.embed_dense.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.embed_dense) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/embed_dense.pdf) 

- :material-rename: **Run ID:** embed_dense 
- :fontawesome-solid-user-group: **Participant:** HEG_Geneva 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `d138e844008fd88dafb6b19b2a5bf65d` 
- :material-text: **Run description:** RRF combination of two transformer-based models: One sentence embedding and one re-ranking transformer trained on MS-Marco 

---
#### f_0_mt5 
[**`Results`**](./results.md#f_0_mt5) | [**`Participants`**](./participants.md#h2oloo) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.f_0_mt5.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.f_0_mt5) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/f_0_mt5.pdf) 

- :material-rename: **Run ID:** f_0_mt5 
- :fontawesome-solid-user-group: **Participant:** h2oloo 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `bbbfc947f4bbf12261c69001b7af34c4` 
- :material-text: **Run description:** First: RRF of 41 different runs, 40 of which run Pyserini's RM3 on queries generated by dT5q and 1 using the standard topic description. Default parameters.  Second: 0-shot med-monoT5 3b reranks all 6-length, 3-stride segments using the title, condition and eligibility fields 

---
#### f_d2q_rm3 
[**`Results`**](./results.md#f_d2q_rm3) | [**`Participants`**](./participants.md#h2oloo) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.f_d2q_rm3.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.f_d2q_rm3) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/f_d2q_rm3.pdf) 

- :material-rename: **Run ID:** f_d2q_rm3 
- :fontawesome-solid-user-group: **Participant:** h2oloo 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `a270c79b472c471a29be676076199a76` 
- :material-text: **Run description:** RRF of 41 different runs, 40 of which run Pyserini's RM3 on queries generated by dT5q and 1 using the standard topic description. Default parameters. 

---
#### f_t_mt5 
[**`Results`**](./results.md#f_t_mt5) | [**`Participants`**](./participants.md#h2oloo) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.f_t_mt5.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.f_t_mt5) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/f_t_mt5.pdf) 

- :material-rename: **Run ID:** f_t_mt5 
- :fontawesome-solid-user-group: **Participant:** h2oloo 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `7fdf13f3b2f63e871f86bb3c507dbf92` 
- :material-text: **Run description:** First: RRF of 41 different runs, 40 of which run Pyserini's RM3 on queries generated by dT5q and 1 using the standard topic description. Default parameters.  Second: Trained med-monoT5 3b (on Koopman & Zuccon (SIGIR 2016)) reranks all 6-length, 3-stride segments using the title, condition and eligibility fields 

---
#### f_t_mt5_2 
[**`Results`**](./results.md#f_t_mt5_2) | [**`Participants`**](./participants.md#h2oloo) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.f_t_mt5_2.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.f_t_mt5_2) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/f_t_mt5_2.pdf) 

- :material-rename: **Run ID:** f_t_mt5_2 
- :fontawesome-solid-user-group: **Participant:** h2oloo 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `2556b470bf9562989b98e84850233f68` 
- :material-text: **Run description:** First: RRF of 41 different runs, 40 of which run Pyserini's RM3 on queries generated by dT5q and 1 using the standard topic description. Default parameters.  Second: Trained med-monoT5 3b (on Koopman & Zuccon (SIGIR 2016)) reranks all 6-length, 3-stride segments to select best eligibility segment and best description segment which are combined and finally reranked. 

---
#### fifth_run 
[**`Results`**](./results.md#fifth_run) | [**`Participants`**](./participants.md#irunidue) | [**`Proceedings`**](./proceedings.md#trec-2021-clinical-trials-retrieval-duisburg-essen-university-submission) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.fifth_run.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.fifth_run) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/fifth_run.pdf) 

- :material-rename: **Run ID:** fifth_run 
- :fontawesome-solid-user-group: **Participant:** IRUniDUE 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `32b725b0a812e13ca9a134775cef8b42` 
- :material-text: **Run description:** BM25 for initial ranking on the clinical trial detailed description and eligibility inclusion criteria with gender and age filtering. Then re-rank the documents by calculating a membership function between the original BM25 scores and bm25 scores on the extracted entities using "en_core_sci_scibert" from the topics and eligibility criteria. 

---
#### first_run 
[**`Results`**](./results.md#first_run) | [**`Participants`**](./participants.md#irunidue) | [**`Proceedings`**](./proceedings.md#trec-2021-clinical-trials-retrieval-duisburg-essen-university-submission) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.first_run.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.first_run) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/first_run.pdf) 

- :material-rename: **Run ID:** first_run 
- :fontawesome-solid-user-group: **Participant:** IRUniDUE 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `19ff1ec0302eb0cfd680516953cb621c` 
- :material-text: **Run description:** BM25 for initial ranking on the eligibility inclusion criteria with gender and age filtering, and then calculate negative scores from the eligibility exclusion criteria as a membership function.  

---
#### fourth_run 
[**`Results`**](./results.md#fourth_run) | [**`Participants`**](./participants.md#irunidue) | [**`Proceedings`**](./proceedings.md#trec-2021-clinical-trials-retrieval-duisburg-essen-university-submission) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.fourth_run.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.fourth_run) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/fourth_run.pdf) 

- :material-rename: **Run ID:** fourth_run 
- :fontawesome-solid-user-group: **Participant:** IRUniDUE 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `b619a9ab1b69398b814a7e7b041f487a` 
- :material-text: **Run description:** BM25 for initial ranking on the clinical trial detailed description and eligibility inclusion criteria with gender and age filtering. Then re-rank the documents by calculating the cousin similarity between the topic Bio_ClinicalBERT and the clinical trial detailed description. 

---
#### FUH_T0 
[**`Results`**](./results.md#fuh_t0) | [**`Participants`**](./participants.md#fuh) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.FUH_T0.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.FUH_T0) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/FUH_T0.pdf) 

- :material-rename: **Run ID:** FUH_T0 
- :fontawesome-solid-user-group: **Participant:** FUH 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `0e1e8638dedac601562937cfc4dc331d` 
- :material-text: **Run description:** We used our own BM25 implementation with default configuration for ranking. We used MeSH Terms and HPO for indexation. Extraction of terms was done without a confidence threshold.  

---
#### FUH_T30 
[**`Results`**](./results.md#fuh_t30) | [**`Participants`**](./participants.md#fuh) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.FUH_T30.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.FUH_T30) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/FUH_T30.pdf) 

- :material-rename: **Run ID:** FUH_T30 
- :fontawesome-solid-user-group: **Participant:** FUH 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `b82b877245a21ca5dfac671d91ee985c` 
- :material-text: **Run description:** We used our own BM25 implementation with default configuration for ranking. We used MeSH Terms and HPO for indexation. Extraction of terms was done with a confidence threshold of 30%.  

---
#### FUHT0NoHpo 
[**`Results`**](./results.md#fuht0nohpo) | [**`Participants`**](./participants.md#fuh) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.FUHT0NoHpo.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.FUHT0NoHpo) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/FUHT0NoHpo.pdf) 

- :material-rename: **Run ID:** FUHT0NoHpo 
- :fontawesome-solid-user-group: **Participant:** FUH 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `3b76007b04e9755fa3f98f24696ebdaf` 
- :material-text: **Run description:** We used our own BM25 implementation with default configuration for ranking. We used MeSH Terms. Extraction of terms was done without a confidence threshold.  

---
#### FUHT30NoHpo 
[**`Results`**](./results.md#fuht30nohpo) | [**`Participants`**](./participants.md#fuh) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.FUHT30NoHpo.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.FUHT30NoHpo) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/FUHT30NoHpo.pdf) 

- :material-rename: **Run ID:** FUHT30NoHpo 
- :fontawesome-solid-user-group: **Participant:** FUH 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `33830c0d492e1260cd5b71c0887a30d9` 
- :material-text: **Run description:** We used our own BM25 implementation with default configuration for ranking. We used MeSH Terms. Extraction of terms was done without a confidence threshold.  

---
#### FUHTD30TQ0 
[**`Results`**](./results.md#fuhtd30tq0) | [**`Participants`**](./participants.md#fuh) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.FUHTD30TQ0.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.FUHTD30TQ0) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/FUHTD30TQ0.pdf) 

- :material-rename: **Run ID:** FUHTD30TQ0 
- :fontawesome-solid-user-group: **Participant:** FUH 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `2c430a601aa2e28de65b85c8e8ad8666` 
- :material-text: **Run description:** We used our own BM25 implementation with default configuration for ranking. We used MeSH Terms and HPO. Extraction of terms from Documents was made with 30% confidence threshold and Queries with 0% confidence threshold.  

---
#### IBMAUTOGT 
[**`Results`**](./results.md#ibmautogt) | [**`Participants`**](./participants.md#ibmresearch) | [**`Proceedings`**](./proceedings.md#ibm-trec-clinical-trials-track-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.IBMAUTOGT.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.IBMAUTOGT) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/IBMAUTOGT.pdf) 

- :material-rename: **Run ID:** IBMAUTOGT 
- :fontawesome-solid-user-group: **Participant:** IBMResearch 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `f11f735d8690209f7748625d8d1a4705` 
- :material-text: **Run description:** This system consists of three modules: 1) query generation module 2) retrieval module and 3) neural re-ranker. The query generation module that relied on IBM Watson Annotator for Clinical Data service, a medical domain NLP service featuring a variety of annotators for detecting metadata such as entities, concepts, concept values, negated spans, hypothetical spans, and a collection of annotators that detect, normalize, and code medical and social findings from unstructured clinical data. Next, based on the observations we made through experimentation on SIGIR-2016 corpora, we developed several heuristics to assign weights to the extracted metadata that can serve as weighted adhoc queries. Finally, these weights along with the metadata, are fed into the retrieval module that includes a) Lucene and b) transformer based semantic textual similarity (STS) model. Next, we select top-N clinical trials for each topic using the ensemble of scores from the retrieval model that are fed into a neural re-ranker. The neural re-ranker is a novel deep learning pipeline that includes two deep learning architectures. As a first step, we trained a state-of-the-art joint concept and relation extraction model using Chia, a large-annotated corpus of clinical trial eligibility criteria for concept and relation extraction from topics. In the next step, we generated silver standard training data by jointly leveraging the structured and unstructured information in MIMIC-III clinical database and structured information in clinical trials.  This results approximately 700K potential positive candidates which we used to train a transformer-based learning-to-rank model that leverages outputs from CHIA in addition to novel attention mechanisms to re-rank the relevant clinical trials given a topic. 

---
#### IBMLucene 
[**`Results`**](./results.md#ibmlucene) | [**`Participants`**](./participants.md#ibmresearch) | [**`Proceedings`**](./proceedings.md#ibm-trec-clinical-trials-track-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.IBMLucene.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.IBMLucene) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/IBMLucene.pdf) 

- :material-rename: **Run ID:** IBMLucene 
- :fontawesome-solid-user-group: **Participant:** IBMResearch 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `951c81f35df8ac875c2e8a9c8dfb8ce6` 
- :material-text: **Run description:** This system consists of two modules 1) query generation module and 2) retriever. As a first step, we developed an unsupervised query generation module that relied on IBM Watson Annotator for Clinical Data service, a medical domain NLP service featuring a variety of annotators for detecting metadata such as entities, concepts, concept values, negated spans, hypothetical spans, and a collection of annotators that detect, normalize, and code medical and social findings from unstructured clinical data. Next, based on the observations we made through experimentation on SIGIR-2016 corpora, we developed several heuristics  to assign weights to the extracted metadata that can serve as weighted adhoc queries. Finally, these weights along with the metadata, are used to retrieve trials using a lucene index. Trials are indexed with the condition and intervention name. We search these fields using the weighted ad-hoc queries, with the weights serving as boosts, and rank by BM25 score. 

---
#### IBMSIGIR 
[**`Results`**](./results.md#ibmsigir) | [**`Participants`**](./participants.md#ibmresearch) | [**`Proceedings`**](./proceedings.md#ibm-trec-clinical-trials-track-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.IBMSIGIR.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.IBMSIGIR) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/IBMSIGIR.pdf) 

- :material-rename: **Run ID:** IBMSIGIR 
- :fontawesome-solid-user-group: **Participant:** IBMResearch 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `5882628595567fb6a4bd33f87e0ba368` 
- :material-text: **Run description:** This system consists of three modules: 1) query generation module 2) retrieval module and 3) neural re-ranker. The query generation module that relied on IBM Watson Annotator for Clinical Data service, a medical domain NLP service featuring a variety of annotators for detecting metadata such as entities, concepts, concept values, negated spans, hypothetical spans, and a collection of annotators that detect, normalize, and code medical and social findings from unstructured clinical data. Next, based on the observations we made through experimentation on SIGIR-2016 corpora, we developed several heuristics to assign weights to the extracted metadata that can serve as weighted adhoc queries. Finally, these weights along with the metadata, are fed into the retrieval module that includes a) Lucene and b) transformer based semantic textual similarity (STS) model. Next, we select top-N clinical trials for each topic using the ensemble of scores from the retrieval model that are fed into a neural re-ranker. The neural re-ranker is a novel deep learning pipeline that includes two deep learning architectures. As a first step, we trained a state-of-the-art joint concept and relation extraction model using Chia, a large-annotated corpus of clinical trial eligibility criteria for concept and relation extraction from topics. In the next step, we use SIGIR-2016 corpora to train a transformer-based learning-to-rank model that leverages outputs from CHIA in addition to novel attention mechanisms to re-rank the relevant clinical trials given a topic. 

---
#### IBMSIGIRACT 
[**`Results`**](./results.md#ibmsigiract) | [**`Participants`**](./participants.md#ibmresearch) | [**`Proceedings`**](./proceedings.md#ibm-trec-clinical-trials-track-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.IBMSIGIRACT.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.IBMSIGIRACT) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/IBMSIGIRACT.pdf) 

- :material-rename: **Run ID:** IBMSIGIRACT 
- :fontawesome-solid-user-group: **Participant:** IBMResearch 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `9d8784c9d0cde97871ecac7c33448fc3` 
- :material-text: **Run description:** This system consists of three modules: 1) query generation module 2) retrieval module and 3) neural re-ranker. The query generation module that relied on IBM Watson Annotator for Clinical Data service, a medical domain NLP service featuring a variety of annotators for detecting metadata such as entities, concepts, concept values, negated spans, hypothetical spans, and a collection of annotators that detect, normalize, and code medical and social findings from unstructured clinical data. Next, based on the observations we made through experimentation on SIGIR-2016 corpora, we developed several heuristics to assign weights to the extracted metadata that can serve as weighted adhoc queries. Finally, these weights along with the metadata, are fed into the retrieval module that includes a) Lucene and b) transformer based semantic textual similarity (STS) model. Next, we select top-N clinical trials for each topic using the ensemble of scores from the retrieval model that are fed into a neural re-ranker. The neural re-ranker is a novel deep learning pipeline that includes two deep learning architectures. As a first step, we trained state-of-the-art joint concept and relation extraction model using Chia, a large-annotated corpus of clinical trial eligibility criteria for concept and relation extraction from topics. In the next step, we use SIGIR-2016 corpora to train a transformer-based learning-to-rank model that leverages outputs from CHIA in addition to novel attention mechanisms to re-rank the relevant clinical trials given a topic. We believe it is worthwhile to understand the true impact of our system as a real-world use case, thus we match the patients against only the trials that are Currently Active (Recruiting, Not-yet-recruiting, Enrolling by invitation, Active not recruiting). 

---
#### IBMSTS 
[**`Results`**](./results.md#ibmsts) | [**`Participants`**](./participants.md#ibmresearch) | [**`Proceedings`**](./proceedings.md#ibm-trec-clinical-trials-track-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.IBMSTS.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.IBMSTS) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/IBMSTS.pdf) 

- :material-rename: **Run ID:** IBMSTS 
- :fontawesome-solid-user-group: **Participant:** IBMResearch 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `050c268851200efa558ead19042e927d` 
- :material-text: **Run description:** This system consists of two modules 1) query generation module and 2) neural retriever. As a first step, we developed an unsupervised query generation module that relied on IBM Watson Annotator for Clinical Data service, a medical domain NLP service featuring a variety of annotators for detecting metadata such as entities, concepts, concept values, negated spans, hypothetical spans, and a collection of annotators that detect, normalize, and code medical and social findings from unstructured clinical data. Next, based on the observations we made through experimentation on SIGIR-2016 corpora, we developed several heuristics to assign weights to the extracted metadata that can serve as weighted adhoc queries. Finally, these weights along with the metadata, are used to retrieve trials using a transformer based semantic textual similarity (STS) model. In summary, Low-dimensional representations are obtained for all the conditions and interventions present in the trials and the extracted metadata of each topic. Next, we measure weight normalized pairwise cosine similarity between a topic and the low-dimensional representations of all the trails to rank them. 

---
#### ielabr1 
[**`Results`**](./results.md#ielabr1) | [**`Participants`**](./participants.md#ielab) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.ielabr1.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.ielabr1) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/ielabr1.pdf) 

- :material-rename: **Run ID:** ielabr1 
- :fontawesome-solid-user-group: **Participant:** ielab 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `bd709a7212b5ee200951ff272faab9e0` 
- :material-text: **Run description:** pyterrier, bm25 default 

---
#### ielabr2 
[**`Results`**](./results.md#ielabr2) | [**`Participants`**](./participants.md#ielab) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.ielabr2.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.ielabr2) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/ielabr2.pdf) 

- :material-rename: **Run ID:** ielabr2 
- :fontawesome-solid-user-group: **Participant:** ielab 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `fb2586b1f25175871a6bb10271001f0d` 
- :material-text: **Run description:** pyterrier, bm25 default, BioBERT 

---
#### ielabr3 
[**`Results`**](./results.md#ielabr3) | [**`Participants`**](./participants.md#ielab) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.ielabr3.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.ielabr3) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/ielabr3.pdf) 

- :material-rename: **Run ID:** ielabr3 
- :fontawesome-solid-user-group: **Participant:** ielab 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `71eadbb48d70a697362734e0f9ea1108` 
- :material-text: **Run description:** pyterrier, bm25 default, Dirichlet default, PL default 

---
#### ielabr4 
[**`Results`**](./results.md#ielabr4) | [**`Participants`**](./participants.md#ielab) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.ielabr4.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.ielabr4) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/ielabr4.pdf) 

- :material-rename: **Run ID:** ielabr4 
- :fontawesome-solid-user-group: **Participant:** ielab 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** manual 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `67ef4f005aaae2e04fef40f6c8e4e06a` 
- :material-text: **Run description:** pyterrier, bm25 default 

---
#### IKR3_BSL 
[**`Results`**](./results.md#ikr3_bsl) | [**`Participants`**](./participants.md#unimib) | [**`Proceedings`**](./proceedings.md#unimib-at-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.IKR3_BSL.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.IKR3_BSL) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/IKR3_BSL.pdf) 

- :material-rename: **Run ID:** IKR3_BSL 
- :fontawesome-solid-user-group: **Participant:** UNIMIB 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `7136b8e93b6385d8609fde05e4be9f3c` 
- :material-text: **Run description:** This model implements a keyword extraction method for every topic and then ranks using BM25 and Pyterrier. 

---
#### IKR3_TT_MW_d 
[**`Results`**](./results.md#ikr3_tt_mw_d) | [**`Participants`**](./participants.md#unimib) | [**`Proceedings`**](./proceedings.md#unimib-at-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.IKR3_TT_MW_d.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.IKR3_TT_MW_d) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/IKR3_TT_MW_d.pdf) 

- :material-rename: **Run ID:** IKR3_TT_MW_d 
- :fontawesome-solid-user-group: **Participant:** UNIMIB 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `340dc00a8469469f82aee598a04df2e6` 
- :material-text: **Run description:** Another Decision theoretic approach in which the whole topic has been used. Topical Relevance has been determined using BM25.  

---
#### IKR3_TT_MW_k 
[**`Results`**](./results.md#ikr3_tt_mw_k) | [**`Participants`**](./participants.md#unimib) | [**`Proceedings`**](./proceedings.md#unimib-at-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.IKR3_TT_MW_k.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.IKR3_TT_MW_k) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/IKR3_TT_MW_k.pdf) 

- :material-rename: **Run ID:** IKR3_TT_MW_k 
- :fontawesome-solid-user-group: **Participant:** UNIMIB 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `24191431cf9c7c7c1d15253394207de6` 
- :material-text: **Run description:** This is a decision theoretic approach. It employs the TOPSIS model to aggregate the topicality scores of different fields. In this case, the topical scores were calculated using BM25. 

---
#### imsFused1 
[**`Results`**](./results.md#imsfused1) | [**`Participants`**](./participants.md#ims_unipd) | [**`Proceedings`**](./proceedings.md#filter-transform-expand-and-fuse-the-ims-unipd-at-trec-2021-clinical-trials) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.imsFused1.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.imsFused1) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/imsFused1.pdf) 

- :material-rename: **Run ID:** imsFused1 
- :fontawesome-solid-user-group: **Participant:** ims_unipd 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `1031c7cce501c11b1f683e124443185f` 
- :material-text: **Run description:** Fusion of BART RM3 + T5 RM3 

---
#### imsFused2 
[**`Results`**](./results.md#imsfused2) | [**`Participants`**](./participants.md#ims_unipd) | [**`Proceedings`**](./proceedings.md#filter-transform-expand-and-fuse-the-ims-unipd-at-trec-2021-clinical-trials) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.imsFused2.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.imsFused2) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/imsFused2.pdf) 

- :material-rename: **Run ID:** imsFused2 
- :fontawesome-solid-user-group: **Participant:** ims_unipd 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `0cc561e7b9f966ad3dbe65933ebced75` 
- :material-text: **Run description:** Fusion of all the previous runs 

---
#### ittc1 
[**`Results`**](./results.md#ittc1) | [**`Participants`**](./participants.md#ittc-aimedtech) | [**`Proceedings`**](./proceedings.md#ittc-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.ittc1.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.ittc1) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/ittc1.pdf) 

- :material-rename: **Run ID:** ittc1 
- :fontawesome-solid-user-group: **Participant:** ITTC-AIMedTech 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `dbabf61f146e05cf7eb1840507659577` 
- :material-text: **Run description:** BM25 with negated entities (query and document); on the document side we reversed the negated/affirmed entities in exclusions and combined them in the same list with inclusions 

---
#### ittc2 
[**`Results`**](./results.md#ittc2) | [**`Participants`**](./participants.md#ittc-aimedtech) | [**`Proceedings`**](./proceedings.md#ittc-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.ittc2.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.ittc2) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/ittc2.pdf) 

- :material-rename: **Run ID:** ittc2 
- :fontawesome-solid-user-group: **Participant:** ITTC-AIMedTech 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `9fa351b0c1450a16ac1f2d1254aec302` 
- :material-text: **Run description:** BM25 plus the most comprehensive query processing (with negation and metadata such as age), matched against the inclusions text, combined keywords and metadata, too; exclusions here are represented in form of reverse negated entities and metadata/clinical variables 

---
#### ittc3 
[**`Results`**](./results.md#ittc3) | [**`Participants`**](./participants.md#ittc-aimedtech) | [**`Proceedings`**](./proceedings.md#ittc-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.ittc3.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.ittc3) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/ittc3.pdf) 

- :material-rename: **Run ID:** ittc3 
- :fontawesome-solid-user-group: **Participant:** ITTC-AIMedTech 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `392e24f5fc1b2d152c26522200fa085e` 
- :material-text: **Run description:** BM25 plus matches a the full text of the query against two indexes - one indexing the title and inclusion criteria, the other indexing the exclusion criteria; then the set difference is taken 

---
#### ittc4 
[**`Results`**](./results.md#ittc4) | [**`Participants`**](./participants.md#ittc-aimedtech) | [**`Proceedings`**](./proceedings.md#ittc-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.ittc4.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.ittc4) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/ittc4.pdf) 

- :material-rename: **Run ID:** ittc4 
- :fontawesome-solid-user-group: **Participant:** ITTC-AIMedTech 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `eca8218c87ac60947e6c273be388ddce` 
- :material-text: **Run description:** BM25 plus matches keyterms of the query against two indexes - one indexing the title and inclusion criteria, the other indexing the exclusion criteria; then the set difference is taken 

---
#### ittc5 
[**`Results`**](./results.md#ittc5) | [**`Participants`**](./participants.md#ittc-aimedtech) | [**`Proceedings`**](./proceedings.md#ittc-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.ittc5.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.ittc5) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/ittc5.pdf) 

- :material-rename: **Run ID:** ittc5 
- :fontawesome-solid-user-group: **Participant:** ITTC-AIMedTech 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `2b13558e508f7328245f982a79579caf` 
- :material-text: **Run description:** BM25 plus matches the key terms of the query against two indexes - one indexing the title and inclusion criteria, the other indexing the exclusion criteria; then the set difference is taken. All negated entities excluded from the query. 

---
#### jbnu1 
[**`Results`**](./results.md#jbnu1) | [**`Participants`**](./participants.md#jbnu) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.jbnu1.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.jbnu1) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/jbnu1.pdf) 

- :material-rename: **Run ID:** jbnu1 
- :fontawesome-solid-user-group: **Participant:** jbnu 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `cf1f491e144df9cb04c684b05fb59a94` 
- :material-text: **Run description:** query expansion using ICD-10 and Wikipedia 

---
#### jbnu2 
[**`Results`**](./results.md#jbnu2) | [**`Participants`**](./participants.md#jbnu) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.jbnu2.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.jbnu2) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/jbnu2.pdf) 

- :material-rename: **Run ID:** jbnu2 
- :fontawesome-solid-user-group: **Participant:** jbnu 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `7f1d0e2bb65e5351728a7131967916ef` 
- :material-text: **Run description:** pseudo relevance feedback + query expansion 

---
#### LaBSE 
[**`Results`**](./results.md#labse) | [**`Participants`**](./participants.md#uni_pais_vasco) | [**`Proceedings`**](./proceedings.md#trec-2021-clinical-trials-submission-for-universidad-del-pais-vasco) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.LaBSE.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.LaBSE) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/LaBSE.pdf) 

- :material-rename: **Run ID:** LaBSE 
- :fontawesome-solid-user-group: **Participant:** uni_pais_vasco 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/11/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `063338547199451941eee2931552627e` 
- :material-text: **Run description:** This model first summarizes the text by extracting medical entities with an NER model trained on I2B2 2010. Next, sentence embeddings are created for these summarized texts using the Language-agnostic BERT sentence embedding model available from Hugging Face. Similarity between documents and topics and computed via cosine similarity.   

---
#### LaBSE_rerank 
[**`Results`**](./results.md#labse_rerank) | [**`Participants`**](./participants.md#uni_pais_vasco) | [**`Proceedings`**](./proceedings.md#trec-2021-clinical-trials-submission-for-universidad-del-pais-vasco) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.LaBSE_rerank.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.LaBSE_rerank) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/LaBSE_rerank.pdf) 

- :material-rename: **Run ID:** LaBSE_rerank 
- :fontawesome-solid-user-group: **Participant:** uni_pais_vasco 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `2b4770d340eab8a5ed1ad7385693a532` 
- :material-text: **Run description:** This model first uses an NER model trained on I2B2 2010 to extract medical entities from texts. Next, the LaBSE model from sentence-transformers (Hugging Face) is used to create document embedding. Lastly, a reranking is performed by performing a weighted average of the aforementioned sentence embeddings and binary vectors (word present in target text vocabulary).  

---
#### mix5E10K128 
[**`Results`**](./results.md#mix5e10k128) | [**`Participants`**](./participants.md#ntu_nlp) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.mix5E10K128.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.mix5E10K128) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/mix5E10K128.pdf) 

- :material-rename: **Run ID:** mix5E10K128 
- :fontawesome-solid-user-group: **Participant:** NTU_NLP 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `d3a4ddae3253b560af61895838edf2dc` 
- :material-text: **Run description:** Siamese BERT-Large model fused with elastic search. Sliding Window overlap is 128, number of elastic search for fused weight sorting is 10000, fused ratio is 0.5 

---
#### mix6E15K128 
[**`Results`**](./results.md#mix6e15k128) | [**`Participants`**](./participants.md#ntu_nlp) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.mix6E15K128.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.mix6E15K128) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/mix6E15K128.pdf) 

- :material-rename: **Run ID:** mix6E15K128 
- :fontawesome-solid-user-group: **Participant:** NTU_NLP 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `fa4b82add004cf38124489c25c371b50` 
- :material-text: **Run description:** Siamese BERT-Large model fused with elastic search. Sliding Window overlap is 128, number of elastic search for fused weight sorting is 15000, fused ratio is 0.6 

---
#### mix6E5k128 
[**`Results`**](./results.md#mix6e5k128) | [**`Participants`**](./participants.md#ntu_nlp) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.mix6E5k128.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.mix6E5k128) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/mix6E5k128.pdf) 

- :material-rename: **Run ID:** mix6E5k128 
- :fontawesome-solid-user-group: **Participant:** NTU_NLP 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `9b5964359382c82e6db0c7d71b7e54b6` 
- :material-text: **Run description:** Siamese BERT-Large model fused with elastic search. Sliding Window overlap is 128, number of elastic search for fused weight sorting is 5000, fused ratio is 0.6 

---
#### mix6E5k64 
[**`Results`**](./results.md#mix6e5k64) | [**`Participants`**](./participants.md#ntu_nlp) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.mix6E5k64.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.mix6E5k64) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/mix6E5k64.pdf) 

- :material-rename: **Run ID:** mix6E5k64 
- :fontawesome-solid-user-group: **Participant:** NTU_NLP 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `e91690a008ea0048d308e30d0fda8afa` 
- :material-text: **Run description:** Siamese BERT-Large model fused with elastic search. Sliding Window overlap is 64, number of elastic search for fused weight sorting is 5000, fused ratio is 0.6 

---
#### postproc 
[**`Results`**](./results.md#postproc) | [**`Participants`**](./participants.md#dossier) | [**`Proceedings`**](./proceedings.md#dossier-at-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.postproc.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.postproc) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/postproc.pdf) 

- :material-rename: **Run ID:** postproc 
- :fontawesome-solid-user-group: **Participant:** DOSSIER 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `6fb92902e82ca83f52e6682ae599a34b` 
- :material-text: **Run description:** bm25 + postprocessing 

---
#### pozAbbrMesh 
[**`Results`**](./results.md#pozabbrmesh) | [**`Participants`**](./participants.md#poznan) | [**`Proceedings`**](./proceedings.md#pozna-n-contribution-to-trec-clinical-trials-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.pozAbbrMesh.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.pozAbbrMesh) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/pozAbbrMesh.pdf) 

- :material-rename: **Run ID:** pozAbbrMesh 
- :fontawesome-solid-user-group: **Participant:** POZNAN 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `31719296c5801b86fbe290c4234b0750` 
- :material-text: **Run description:** elasticsearch, BM25, fields: summary, description, titles (both), intervention, mesh terms, condition 

---
#### pozAddTerms 
[**`Results`**](./results.md#pozaddterms) | [**`Participants`**](./participants.md#poznan) | [**`Proceedings`**](./proceedings.md#pozna-n-contribution-to-trec-clinical-trials-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.pozAddTerms.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.pozAddTerms) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/pozAddTerms.pdf) 

- :material-rename: **Run ID:** pozAddTerms 
- :fontawesome-solid-user-group: **Participant:** POZNAN 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** manual 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `7178d0007532ed947a0e1dd3a51226b5` 
- :material-text: **Run description:** elasticsearch, BM25, fields: summary, description, titles (both), intervention, mesh terms, condition 

---
#### pozFulltext 
[**`Results`**](./results.md#pozfulltext) | [**`Participants`**](./participants.md#poznan) | [**`Proceedings`**](./proceedings.md#pozna-n-contribution-to-trec-clinical-trials-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.pozFulltext.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.pozFulltext) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/pozFulltext.pdf) 

- :material-rename: **Run ID:** pozFulltext 
- :fontawesome-solid-user-group: **Participant:** POZNAN 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `c05123d61c650c53f42fcb4bcb7fcc74` 
- :material-text: **Run description:** elasticsearch, BM25, fields: summary, description, titles (both) 

---
#### pozMeshTerms 
[**`Results`**](./results.md#pozmeshterms) | [**`Participants`**](./participants.md#poznan) | [**`Proceedings`**](./proceedings.md#pozna-n-contribution-to-trec-clinical-trials-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.pozMeshTerms.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.pozMeshTerms) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/pozMeshTerms.pdf) 

- :material-rename: **Run ID:** pozMeshTerms 
- :fontawesome-solid-user-group: **Participant:** POZNAN 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `86967349f8e5d96a3b81c936c827206c` 
- :material-text: **Run description:** elasticsearch, BM25, fields: summary, description, titles (both), condition, intervention, mesh terms 

---
#### pozTermFds 
[**`Results`**](./results.md#poztermfds) | [**`Participants`**](./participants.md#poznan) | [**`Proceedings`**](./proceedings.md#pozna-n-contribution-to-trec-clinical-trials-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.pozTermFds.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.pozTermFds) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/pozTermFds.pdf) 

- :material-rename: **Run ID:** pozTermFds 
- :fontawesome-solid-user-group: **Participant:** POZNAN 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `1d713cd51bbb58aab470a8d175f776a8` 
- :material-text: **Run description:** elasticsearch, BM25, fields: condition, intervention, mesh terms 

---
#### rerank2000 
[**`Results`**](./results.md#rerank2000) | [**`Participants`**](./participants.md#dossier) | [**`Proceedings`**](./proceedings.md#dossier-at-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.rerank2000.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.rerank2000) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/rerank2000.pdf) 

- :material-rename: **Run ID:** rerank2000 
- :fontawesome-solid-user-group: **Participant:** DOSSIER 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `7306f487e5197bc1afe298f4f2769aba` 
- :material-text: **Run description:** bm25 + postprocessing + reranking based on eligibility with pretrained allenai-specter model 

---
#### RM3Filtered 
[**`Results`**](./results.md#rm3filtered) | [**`Participants`**](./participants.md#ims_unipd) | [**`Proceedings`**](./proceedings.md#filter-transform-expand-and-fuse-the-ims-unipd-at-trec-2021-clinical-trials) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.RM3Filtered.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.RM3Filtered) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/RM3Filtered.pdf) 

- :material-rename: **Run ID:** RM3Filtered 
- :fontawesome-solid-user-group: **Participant:** ims_unipd 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `da28358e7424fff7e0384d115293c953` 
- :material-text: **Run description:** BM25 + RM3 pseudo relevance feedback 

---
#### rrf_all 
[**`Results`**](./results.md#rrf_all) | [**`Participants`**](./participants.md#heg_geneva) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.rrf_all.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.rrf_all) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/rrf_all.pdf) 

- :material-rename: **Run ID:** rrf_all 
- :fontawesome-solid-user-group: **Participant:** HEG_Geneva 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `1c7df6f312e1dcb3d19b12989d78c298` 
- :material-text: **Run description:** RRF combination of the 2 BM25 models, the 2 unsupervised transformers and the supervised model fine-tuned on 2015 qrels 

---
#### RRMATCH 
[**`Results`**](./results.md#rrmatch) | [**`Participants`**](./participants.md#nistrr) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.RRMATCH.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.RRMATCH) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/RRMATCH.pdf) 

- :material-rename: **Run ID:** RRMATCH 
- :fontawesome-solid-user-group: **Participant:** NISTRR 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `629b49c0ecd0e2564ef16873b6585322` 
- :material-text: **Run description:** This uses our own Parmenides structural phrase-matching retrieval model. 

---
#### RUN0 
[**`Results`**](./results.md#run0) | [**`Participants`**](./participants.md#clinical_trials) | [**`Proceedings`**](./proceedings.md#an-approach-to-relevant-clinical-trials-retrieving) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.RUN0.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.RUN0) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/RUN0.pdf) 

- :material-rename: **Run ID:** RUN0 
- :fontawesome-solid-user-group: **Participant:** clinical_trials 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `df5589cd8cb4d687f237d50152463c8a` 
- :material-text: **Run description:** Our own model based on open source algorithms. 1. "LIKE" query to the database with named entities extracted from topics. We trained named entities extraction on the CHIA corpus. 2. Extracting named entities from trials found. 3. Further filtering on exclusion criteria. 4. Sorting based on cosine distances. 

---
#### RUN1FREQS 
[**`Results`**](./results.md#run1freqs) | [**`Participants`**](./participants.md#clinical_trials) | [**`Proceedings`**](./proceedings.md#an-approach-to-relevant-clinical-trials-retrieving) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.RUN1FREQS.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.RUN1FREQS) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/RUN1FREQS.pdf) 

- :material-rename: **Run ID:** RUN1FREQS 
- :fontawesome-solid-user-group: **Participant:** clinical_trials 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `078795a3a55f1eadf6e5c39974f03c6e` 
- :material-text: **Run description:** Our own model based on open source algorithms. 1."LIKE" queries to the trials database by named entities extracted from topics. 2. Trials are sorted by named entities frequencies (rare diseases are of highest relevance) 3. Filtering by named entities extracted from exclusion criteria. 

---
#### RUN3SENTS 
[**`Results`**](./results.md#run3sents) | [**`Participants`**](./participants.md#clinical_trials) | [**`Proceedings`**](./proceedings.md#an-approach-to-relevant-clinical-trials-retrieving) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.RUN3SENTS.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.RUN3SENTS) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/RUN3SENTS.pdf) 

- :material-rename: **Run ID:** RUN3SENTS 
- :fontawesome-solid-user-group: **Participant:** clinical_trials 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `fb18c6af53f8c42c1091e289a61d4e9a` 
- :material-text: **Run description:** Our own based on open-source algorithms. Everything was as in our first run, but we used sentence embeddings instead of word embeddings. 

---
#### seansct01 
[**`Results`**](./results.md#seansct01) | [**`Participants`**](./participants.md#v-ryerson) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.seansct01.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.seansct01) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/seansct01.pdf) 

- :material-rename: **Run ID:** seansct01 
- :fontawesome-solid-user-group: **Participant:** V-Ryerson 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `cd0f017d1b43da5f802c77fbb478e254` 
- :material-text: **Run description:** BM25+  

---
#### second_run 
[**`Results`**](./results.md#second_run) | [**`Participants`**](./participants.md#irunidue) | [**`Proceedings`**](./proceedings.md#trec-2021-clinical-trials-retrieval-duisburg-essen-university-submission) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.second_run.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.second_run) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/second_run.pdf) 

- :material-rename: **Run ID:** second_run 
- :fontawesome-solid-user-group: **Participant:** IRUniDUE 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `ae0a86dfdb7d716596888329bfa61382` 
- :material-text: **Run description:** BM25 for initial ranking on the clinical trial detailed description with gender and age filtering. Then re-rank the documents by calculating the BM25 for both eligibility exclusion and inclusion criteria. The final score is the subtraction of the inclusion and exclusion scores.  

---
#### SIBTMct1 
[**`Results`**](./results.md#sibtmct1) | [**`Participants`**](./participants.md#bitem) | [**`Proceedings`**](./proceedings.md#sib-text-mining-at-trec-clinical-trials-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.SIBTMct1.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.SIBTMct1) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/SIBTMct1.pdf) 

- :material-rename: **Run ID:** SIBTMct1 
- :fontawesome-solid-user-group: **Participant:** BITEM 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `9ca2c44fd7c4529c171add6d98a993ac` 
- :material-text: **Run description:** Upstream from the queries: Topics and CT processing: annotations based on NCIt, ICD, SNOMED and MESH ontologies. Common pipeline for each run (query): - Gender and age of patient have to be in accordance to the recruitment criteria of the CT (exact gender or "all";  age min <= age of patient <= age max)  - annotations codes in some CT fields (brief title, official title, brief summary, detailed description, condition, study population, criteria, inclusion criteria, keywords and mesh terms) - If annotation code of topic found in the "exclusion criteria" of the CT, CT is rejected. Query details: MUST: Annotations codes ICD are required in particular CT fields. SHOULD: Annotations codes NCI, SNOMED and MESH are required in particular CT fields. Large boost for matching in "inclusion criteria" field. Boost for NCI and MESH matching. If no results for topic, add results from run 2, a one grade more relaxed query. 

---
#### SIBTMct2 
[**`Results`**](./results.md#sibtmct2) | [**`Participants`**](./participants.md#bitem) | [**`Proceedings`**](./proceedings.md#sib-text-mining-at-trec-clinical-trials-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.SIBTMct2.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.SIBTMct2) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/SIBTMct2.pdf) 

- :material-rename: **Run ID:** SIBTMct2 
- :fontawesome-solid-user-group: **Participant:** BITEM 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `c9b2e8bf668a333e80a7332639ef8649` 
- :material-text: **Run description:** Upstream from the queries: Topics and CT processing: annotations based on NCIt, ICD, SNOMED and MESH ontologies. Common pipeline for each run (query): - Gender and age of patient have to be in accordance to the recruitment criteria of the CT (exact gender or "all";  age min <= age of patient <= age max)  - annotations codes in some CT fields (brief title, official title, brief summary, detailed description, condition, study population, criteria, inclusion criteria, keywords and mesh terms) - If annotation code of topic found in the "exclusion criteria" of the CT, CT is rejected. Query details: SHOULD: All annotations codes NCI, SNOMED and MESH should be present in particular CT fields. Large boost for matching in "inclusion criteria" field. Boost for NCI, ICD and MESH matching. 

---
#### SIBTMct3 
[**`Results`**](./results.md#sibtmct3) | [**`Participants`**](./participants.md#bitem) | [**`Proceedings`**](./proceedings.md#sib-text-mining-at-trec-clinical-trials-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.SIBTMct3.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.SIBTMct3) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/SIBTMct3.pdf) 

- :material-rename: **Run ID:** SIBTMct3 
- :fontawesome-solid-user-group: **Participant:** BITEM 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `0d96a114b8bf952d04e1c9e6d0e83882` 
- :material-text: **Run description:** Upstream from the queries: Topics and CT processing: annotations based on NCIt, ICD, SNOMED and MESH ontologies. Common pipeline for each run (query): - Gender and age of patient have to be in accordance to the recruitment criteria of the CT (exact gender or "all";  age min <= age of patient <= age max)  - annotations codes in some CT fields (brief title, official title, brief summary, detailed description, condition, study population, criteria, inclusion criteria, keywords and mesh terms) - If annotation code of topic found in the "exclusion criteria" of the CT, CT is rejected. Query details: SHOULD: All annotations codes NCI, SNOMED and MESH should be present in particular CT fields. Large boost for matching in "inclusion criteria" field. Boost for matching in "keywords" field. Boost for NCI, ICD and MESH matching. 

---
#### SIBTMct4 
[**`Results`**](./results.md#sibtmct4) | [**`Participants`**](./participants.md#bitem) | [**`Proceedings`**](./proceedings.md#sib-text-mining-at-trec-clinical-trials-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.SIBTMct4.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.SIBTMct4) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/SIBTMct4.pdf) 

- :material-rename: **Run ID:** SIBTMct4 
- :fontawesome-solid-user-group: **Participant:** BITEM 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `63110a914cec48af3142fd367c267a56` 
- :material-text: **Run description:** Upstream from the queries: Topics and CT processing: annotations based on NCIt, ICD, SNOMED and MESH ontologies. Common pipeline for each run (query): - Gender and age of patient have to be in accordance to the recruitment criteria of the CT (exact gender or "all";  age min <= age of patient <= age max)  - annotations codes in some CT fields (brief title, official title, brief summary, detailed description, condition, study population, criteria, inclusion criteria, keywords and mesh terms) - If annotation code of topic found in the "exclusion criteria" of the CT, CT is rejected. Query details: SHOULD: All annotations codes NCI, SNOMED and MESH should be present in particular CT fields. Large boost for matching in "inclusion criteria" field. Boost for matching in "mesh_terms" field. Boost for NCI, ICD and MESH matching. 

---
#### SIBTMct5 
[**`Results`**](./results.md#sibtmct5) | [**`Participants`**](./participants.md#bitem) | [**`Proceedings`**](./proceedings.md#sib-text-mining-at-trec-clinical-trials-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.SIBTMct5.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.SIBTMct5) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/SIBTMct5.pdf) 

- :material-rename: **Run ID:** SIBTMct5 
- :fontawesome-solid-user-group: **Participant:** BITEM 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `04dabe416e187b71ef60383f80056945` 
- :material-text: **Run description:** Upstream from the queries: Topics and CT processing: annotations based on NCIt, ICD, SNOMED and MESH ontologies. Common pipeline for each run (query): - Gender and age of patient have to be in accordance to the recruitment criteria of the CT (exact gender or "all";  age min <= age of patient <= age max)  - annotations codes in some CT fields (brief title, official title, brief summary, detailed description, condition, study population, criteria, inclusion criteria, keywords and mesh terms) - If annotation code of topic found in the "exclusion criteria" of the CT, CT is rejected. Query details: SHOULD: All annotations codes NCI, SNOMED and MESH should be present in particular CT fields. Large boost for matching in "inclusion criteria" field. Boost for matching in "description_detailed" field. Boost for NCI, ICD and MESH matching. 

---
#### spec_rrk_fqv 
[**`Results`**](./results.md#spec_rrk_fqv) | [**`Participants`**](./participants.md#uni_pais_vasco) | [**`Proceedings`**](./proceedings.md#trec-2021-clinical-trials-submission-for-universidad-del-pais-vasco) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.spec_rrk_fqv.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.spec_rrk_fqv) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/spec_rrk_fqv.pdf) 

- :material-rename: **Run ID:** spec_rrk_fqv 
- :fontawesome-solid-user-group: **Participant:** uni_pais_vasco 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `89408acd8da66e343716cde0a4be14d5` 
- :material-text: **Run description:**  This model first uses an NER model trained on I2B2 2010 to extract medical entities from texts. Next, the allenai-specter model from sentence-transformers (Hugging Face) is used to create document embedding. Lastly, a reranking is performed by performing a weighted average of the aforementioned sentence embeddings and frequency vectors (frequency of words present in target text vocabulary).  

---
#### spect_rerank 
[**`Results`**](./results.md#spect_rerank) | [**`Participants`**](./participants.md#uni_pais_vasco) | [**`Proceedings`**](./proceedings.md#trec-2021-clinical-trials-submission-for-universidad-del-pais-vasco) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.spect_rerank.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.spect_rerank) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/spect_rerank.pdf) 

- :material-rename: **Run ID:** spect_rerank 
- :fontawesome-solid-user-group: **Participant:** uni_pais_vasco 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `10abcc482262038b5cfcdc8c00adf0d8` 
- :material-text: **Run description:** This model first uses an NER model trained on I2B2 2010 to extract medical entities from texts. Next, the allenai-specter model from sentence-transformers (Hugging Face) is used to create document embedding. Lastly, a reranking is performed by performing a weighted average of the aforementioned sentence embeddings and binary vectors (word present in target text vocabulary).   

---
#### specter 
[**`Results`**](./results.md#specter) | [**`Participants`**](./participants.md#uni_pais_vasco) | [**`Proceedings`**](./proceedings.md#trec-2021-clinical-trials-submission-for-universidad-del-pais-vasco) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.specter.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.specter) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/specter.pdf) 

- :material-rename: **Run ID:** specter 
- :fontawesome-solid-user-group: **Participant:** uni_pais_vasco 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/11/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `4ed09cad5ebb5737e055d868cc41b399` 
- :material-text: **Run description:** This model first summarizes the text by extracting medical entities with an NER model trained on I2B2 2010. Next, sentence embeddings are created for these summarized texts using the allenai-specter sentence transformer model available from Hugging Face. Similarity between documents and topics and computed via cosine similarity.  

---
#### superv_map 
[**`Results`**](./results.md#superv_map) | [**`Participants`**](./participants.md#heg_geneva) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.superv_map.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.superv_map) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/superv_map.pdf) 

- :material-rename: **Run ID:** superv_map 
- :fontawesome-solid-user-group: **Participant:** HEG_Geneva 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `3193a49d5beb932101044a139dd6cbdf` 
- :material-text: **Run description:** RRF combination of BM25 on metamap-enriched queries, and sentence embedding with an MLP fine-tuned on the 2015 qrels. 

---
#### T5RM3Filt 
[**`Results`**](./results.md#t5rm3filt) | [**`Participants`**](./participants.md#ims_unipd) | [**`Proceedings`**](./proceedings.md#filter-transform-expand-and-fuse-the-ims-unipd-at-trec-2021-clinical-trials) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.T5RM3Filt.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.T5RM3Filt) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/T5RM3Filt.pdf) 

- :material-rename: **Run ID:** T5RM3Filt 
- :fontawesome-solid-user-group: **Participant:** ims_unipd 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `97a5d14fc54c608256ed82c402a1a301` 
- :material-text: **Run description:** BM25 + T5 Summary + RM3 pseudo RF 

---
#### tdminerrun1 
[**`Results`**](./results.md#tdminerrun1) | [**`Participants`**](./participants.md#tdminer) | [**`Proceedings`**](./proceedings.md#the-application-of-traditional-ie-as-a-non-traditional-method-in-an-ir-task-tdminer-at-2021-trec-clinical-trials) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.tdminerrun1.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.tdminerrun1) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/tdminerrun1.pdf) 

- :material-rename: **Run ID:** tdminerrun1 
- :fontawesome-solid-user-group: **Participant:** TDMINER 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** manual 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `b75a96e03bbb7f655ebbc2aa06afc39f` 
- :material-text: **Run description:** Own model. IE-based method. 

---
#### tdminerrun2 
[**`Results`**](./results.md#tdminerrun2) | [**`Participants`**](./participants.md#tdminer) | [**`Proceedings`**](./proceedings.md#the-application-of-traditional-ie-as-a-non-traditional-method-in-an-ir-task-tdminer-at-2021-trec-clinical-trials) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.tdminerrun2.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.tdminerrun2) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/tdminerrun2.pdf) 

- :material-rename: **Run ID:** tdminerrun2 
- :fontawesome-solid-user-group: **Participant:** TDMINER 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** manual 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `1d1ceb7d38401822490feac554e2b85d` 
- :material-text: **Run description:** Own model. IE-based method. 

---
#### tdminerrun3 
[**`Results`**](./results.md#tdminerrun3) | [**`Participants`**](./participants.md#tdminer) | [**`Proceedings`**](./proceedings.md#the-application-of-traditional-ie-as-a-non-traditional-method-in-an-ir-task-tdminer-at-2021-trec-clinical-trials) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.tdminerrun3.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.tdminerrun3) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/tdminerrun3.pdf) 

- :material-rename: **Run ID:** tdminerrun3 
- :fontawesome-solid-user-group: **Participant:** TDMINER 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** manual 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `417bb364bf7a9ed1ca9ffb46ad1b2e86` 
- :material-text: **Run description:** Own model. IE-based method. 

---
#### tdminerrun4 
[**`Results`**](./results.md#tdminerrun4) | [**`Participants`**](./participants.md#tdminer) | [**`Proceedings`**](./proceedings.md#the-application-of-traditional-ie-as-a-non-traditional-method-in-an-ir-task-tdminer-at-2021-trec-clinical-trials) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.tdminerrun4.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.tdminerrun4) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/tdminerrun4.pdf) 

- :material-rename: **Run ID:** tdminerrun4 
- :fontawesome-solid-user-group: **Participant:** TDMINER 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** manual 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `c54ad68a8276ff27936b7644b1c14ad4` 
- :material-text: **Run description:** Own model. IE-based method. 

---
#### third_run 
[**`Results`**](./results.md#third_run) | [**`Participants`**](./participants.md#irunidue) | [**`Proceedings`**](./proceedings.md#trec-2021-clinical-trials-retrieval-duisburg-essen-university-submission) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.third_run.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.third_run) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/third_run.pdf) 

- :material-rename: **Run ID:** third_run 
- :fontawesome-solid-user-group: **Participant:** IRUniDUE 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `3f19f962ead51075f81fcc5c661d56a8` 
- :material-text: **Run description:** BM25 for ranking documents based on the clinical trial eligibility inclusion and the boosted topic entities extracted using "en_core_sci_scibert" on the detailed description with gender and age filtering. 

---
#### TxtInc 
[**`Results`**](./results.md#txtinc) | [**`Participants`**](./participants.md#gu_biomed) | [**`Proceedings`**](./proceedings.md#clinical-trial-search-using-lucene-and-umls) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.TxtInc.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.TxtInc) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/TxtInc.pdf) 

- :material-rename: **Run ID:** TxtInc 
- :fontawesome-solid-user-group: **Participant:** GU_BioMed 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `43697b24c4c07f9d78466d8020a0be69` 
- :material-text: **Run description:** This run uses our own model based on free-text search using the Apache Lucene search engine. While each patient profile was considered as a query, all the clinical study condition and inclusion criteria free texts were organized into a database. For each patient, the search results were sorted using the Lucene scores searched against the database. 

---
#### TxtIncExc 
[**`Results`**](./results.md#txtincexc) | [**`Participants`**](./participants.md#gu_biomed) | [**`Proceedings`**](./proceedings.md#clinical-trial-search-using-lucene-and-umls) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.TxtIncExc.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.TxtIncExc) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/TxtIncExc.pdf) 

- :material-rename: **Run ID:** TxtIncExc 
- :fontawesome-solid-user-group: **Participant:** GU_BioMed 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `1f74f7df775518681c8d997c9f8344d3` 
- :material-text: **Run description:** This run uses our own model based on free-text search using the Apache Lucene search engine. While all the clinical study condition and inclusion criteria were put in one database, the exclusion criteria were organized into another database. Using each patient profile as a query, the search results were sorted using the difference of the two Lucene scores searched against the two databases, respectively. 

---
#### TxtIncExcExp 
[**`Results`**](./results.md#txtincexcexp) | [**`Participants`**](./participants.md#gu_biomed) | [**`Proceedings`**](./proceedings.md#clinical-trial-search-using-lucene-and-umls) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.TxtIncExcExp.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.TxtIncExcExp) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/TxtIncExcExp.pdf) 

- :material-rename: **Run ID:** TxtIncExcExp 
- :fontawesome-solid-user-group: **Participant:** GU_BioMed 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `22418cf9f59eb73b9b8c7f6e8700594b` 
- :material-text: **Run description:** This run uses our own model based on free-text search using the Apache Lucene search engine. In this run, all the condition terms for each clinical study were expanded with their child terms in MeSH. While all the expanded condition and the inclusion criteria were put in one database, the exclusion criteria were organized into another database. Using each patient profile as a query, the search results were sorted using the difference of the two Lucene scores searched against the two databases, respectively. 

---
#### UNM_4 
[**`Results`**](./results.md#unm_4) | [**`Participants`**](./participants.md#unimib) | [**`Proceedings`**](./proceedings.md#unimib-at-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.UNM_4.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.UNM_4) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/UNM_4.pdf) 

- :material-rename: **Run ID:** UNM_4 
- :fontawesome-solid-user-group: **Participant:** UNIMIB 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `732b42371b299c56e91a44ff5fd4d28f` 
- :material-text: **Run description:** DFR from pyterrier and a Bert model fine tuned for reranking 

---
#### UNM_5 
[**`Results`**](./results.md#unm_5) | [**`Participants`**](./participants.md#unimib) | [**`Proceedings`**](./proceedings.md#unimib-at-trec-2021-clinical-trials-track) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.UNM_5.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.UNM_5) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/UNM_5.pdf) 

- :material-rename: **Run ID:** UNM_5 
- :fontawesome-solid-user-group: **Participant:** UNIMIB 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/17/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `d0aab4e06a0b2bc1d8f59250841ce02a` 
- :material-text: **Run description:** DFR from pyterrier and a Bert model fine tuned for reranking 

---
#### UNTIIARUN1 
[**`Results`**](./results.md#untiiarun1) | [**`Participants`**](./participants.md#untiia) | [**`Proceedings`**](./proceedings.md#untiia-lab-at-trec-2021-clinical-trial) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.UNTIIARUN1.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.UNTIIARUN1) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/UNTIIARUN1.pdf) 

- :material-rename: **Run ID:** UNTIIARUN1 
- :fontawesome-solid-user-group: **Participant:** UNTIIA 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `ae8d3ea25c3282c2b176aa7ec8fed2c5` 
- :material-text: **Run description:** BM25 from Elastic search (https://www.elastic.co/) 

---
#### UNTIIARUN2 
[**`Results`**](./results.md#untiiarun2) | [**`Participants`**](./participants.md#untiia) | [**`Proceedings`**](./proceedings.md#untiia-lab-at-trec-2021-clinical-trial) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.UNTIIARUN2.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.UNTIIARUN2) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/UNTIIARUN2.pdf) 

- :material-rename: **Run ID:** UNTIIARUN2 
- :fontawesome-solid-user-group: **Participant:** UNTIIA 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** manual 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `2bb623c47be95965b3d2c4330d626a84` 
- :material-text: **Run description:** BM25 from Elastic search (https://www.elastic.co/) 

---
#### UNTIIARUN3 
[**`Results`**](./results.md#untiiarun3) | [**`Participants`**](./participants.md#untiia) | [**`Proceedings`**](./proceedings.md#untiia-lab-at-trec-2021-clinical-trial) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.UNTIIARUN3.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.UNTIIARUN3) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/UNTIIARUN3.pdf) 

- :material-rename: **Run ID:** UNTIIARUN3 
- :fontawesome-solid-user-group: **Participant:** UNTIIA 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** manual 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `d08425f1576faefdfcf7fa392a07040f` 
- :material-text: **Run description:** BM25 from Elastic search (https://www.elastic.co/) 

---
#### UNTIIARUN4 
[**`Results`**](./results.md#untiiarun4) | [**`Participants`**](./participants.md#untiia) | [**`Proceedings`**](./proceedings.md#untiia-lab-at-trec-2021-clinical-trial) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.UNTIIARUN4.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.UNTIIARUN4) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/UNTIIARUN4.pdf) 

- :material-rename: **Run ID:** UNTIIARUN4 
- :fontawesome-solid-user-group: **Participant:** UNTIIA 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** manual 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `69d6b4ad81ac0b4832455e5dfac3a5d4` 
- :material-text: **Run description:** BM25 from Elastic search (https://www.elastic.co/) 

---
#### UNTIIARUN5 
[**`Results`**](./results.md#untiiarun5) | [**`Participants`**](./participants.md#untiia) | [**`Proceedings`**](./proceedings.md#untiia-lab-at-trec-2021-clinical-trial) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.UNTIIARUN5.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.UNTIIARUN5) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/UNTIIARUN5.pdf) 

- :material-rename: **Run ID:** UNTIIARUN5 
- :fontawesome-solid-user-group: **Participant:** UNTIIA 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** manual 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `f0937ed602b5358c58fc2f01e8ed5465` 
- :material-text: **Run description:** BM25 from Elastic search (https://www.elastic.co/) 

---
#### vohbm25 
[**`Results`**](./results.md#vohbm25) | [**`Participants`**](./participants.md#vohcolab) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.vohbm25.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.vohbm25) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/vohbm25.pdf) 

- :material-rename: **Run ID:** vohbm25 
- :fontawesome-solid-user-group: **Participant:** vohcolab 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `f62013bb2b6b741dc002e10c80e93093` 
- :material-text: **Run description:** BM25 baseline tuned with CSIRO collection 

---
#### vohbm25KE 
[**`Results`**](./results.md#vohbm25ke) | [**`Participants`**](./participants.md#vohcolab) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.vohbm25KE.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.vohbm25KE) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/vohbm25KE.pdf) 

- :material-rename: **Run ID:** vohbm25KE 
- :fontawesome-solid-user-group: **Participant:** vohcolab 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `2c880c83580c26d657a82dc87981cfcc` 
- :material-text: **Run description:** bm25 with keyword extraction from query 

---
#### vohCBsim 
[**`Results`**](./results.md#vohcbsim) | [**`Participants`**](./participants.md#vohcolab) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.vohCBsim.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.vohCBsim) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/vohCBsim.pdf) 

- :material-rename: **Run ID:** vohCBsim 
- :fontawesome-solid-user-group: **Participant:** vohcolab 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `ab1310012b585da865cfef4cb23ee2c4` 
- :material-text: **Run description:** bm25 with clinical bert embedding cosine similarity vs topics reranking 

---
#### vohDemo 
[**`Results`**](./results.md#vohdemo) | [**`Participants`**](./participants.md#vohcolab) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.vohDemo.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.vohDemo) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/vohDemo.pdf) 

- :material-rename: **Run ID:** vohDemo 
- :fontawesome-solid-user-group: **Participant:** vohcolab 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `968c558735a9ba491d3319e42ff1c232` 
- :material-text: **Run description:** bm25 to retrieve 10k, linear re-ranking with gender and age features 

---
#### vohl2r5 
[**`Results`**](./results.md#vohl2r5) | [**`Participants`**](./participants.md#vohcolab) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.vohl2r5.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.vohl2r5) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/vohl2r5.pdf) 

- :material-rename: **Run ID:** vohl2r5 
- :fontawesome-solid-user-group: **Participant:** vohcolab 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `1c1a7b2955cecd008882e05d0fae371e` 
- :material-text: **Run description:** learn 2 rank with bm25, age matching, gender matching and MESH related features. 

---
#### wpm_biobert 
[**`Results`**](./results.md#wpm_biobert) | [**`Participants`**](./participants.md#wispermedtxt) | [**`Proceedings`**](./proceedings.md#wispermed-text-at-trec-clinical-trials-track-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.wpm_biobert.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.wpm_biobert) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/wpm_biobert.pdf) 

- :material-rename: **Run ID:** wpm_biobert 
- :fontawesome-solid-user-group: **Participant:** wispermedtxt 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `7bdbb7014b4e2ab96a9ba5c350433178` 
- :material-text: **Run description:** Dense (biobert embeddings) and sparse (tfidf) weighted similarity between topics and trials (title + brief summary). All trials were filtered for including age and gender of each topic. Age and gender were previously extracted from topics using regular expressions. 

---
#### wpm_bmre 
[**`Results`**](./results.md#wpm_bmre) | [**`Participants`**](./participants.md#wispermedtxt) | [**`Proceedings`**](./proceedings.md#wispermed-text-at-trec-clinical-trials-track-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.wpm_bmre.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.wpm_bmre) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/wpm_bmre.pdf) 

- :material-rename: **Run ID:** wpm_bmre 
- :fontawesome-solid-user-group: **Participant:** wispermedtxt 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `b329d0c1548b5bd6127c04f122cbc0df` 
- :material-text: **Run description:** BM25 Ranking with Elasticsearch indexing. All results were then reranked based on weighted tfidf & biobert embedding topic to title + brief_summary similarity. 

---
#### wpm_CBert 
[**`Results`**](./results.md#wpm_cbert) | [**`Participants`**](./participants.md#wispermedtxt) | [**`Proceedings`**](./proceedings.md#wispermed-text-at-trec-clinical-trials-track-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.wpm_CBert.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.wpm_CBert) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/wpm_CBert.pdf) 

- :material-rename: **Run ID:** wpm_CBert 
- :fontawesome-solid-user-group: **Participant:** wispermedtxt 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `00896f0713b68ba8a365677584bdcfcb` 
- :material-text: **Run description:** Bio_ClinicalBERT Embeddings: Cosine Similarity between Topics and Trials (Title + Brief_Summary). Trials were filtered for matching age + gender (obtained through regular expressions). 

---
#### wpm_critumls 
[**`Results`**](./results.md#wpm_critumls) | [**`Participants`**](./participants.md#wispermedtxt) | [**`Proceedings`**](./proceedings.md#wispermed-text-at-trec-clinical-trials-track-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.wpm_critumls.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.wpm_critumls) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/wpm_critumls.pdf) 

- :material-rename: **Run ID:** wpm_critumls 
- :fontawesome-solid-user-group: **Participant:** wispermedtxt 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/19/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `997afe32981a1ca4ca050736e36163ca` 
- :material-text: **Run description:** Trials were lexicographically ordered: First by shared UMLS codes in trial title and topics, second by jaccard index for inclusion criteria and finally by jaccard index for exclusion criteria. The UMLS codes were weighted inversely to the number of trials in which they occur. 

---
#### wpm_KWBM25 
[**`Results`**](./results.md#wpm_kwbm25) | [**`Participants`**](./participants.md#wispermedtxt) | [**`Proceedings`**](./proceedings.md#wispermed-text-at-trec-clinical-trials-track-2021) | [**`Input`**](https://trec.nist.gov/results/trec30/trials/input.wpm_KWBM25.gz) | [**`Summary`**](https://trec.nist.gov/results/trec30/trials/summary.wpm_KWBM25) | [**`Appendix`**](https://trec.nist.gov/pubs/trec30/appendices/trials/wpm_KWBM25.pdf) 

- :material-rename: **Run ID:** wpm_KWBM25 
- :fontawesome-solid-user-group: **Participant:** wispermedtxt 
- :material-format-text: **Track:** Clinical Trials 
- :material-calendar: **Year:** 2021 
- :material-upload: **Submission:** 8/18/2021 
- :fontawesome-solid-user-gear: **Type:** automatic 
- :material-text-search: **Task:** primary 
- :material-fingerprint: **MD5:** `520aa446100045a9732ee3233891390a` 
- :material-text: **Run description:** Keyword extraction from topics using KeyBert with the model Bio_ClinicalBERT. Ranking based on BM25 between keywords and title + brief_summary. Trials have been filtered to match age and gender. 

---
